Ventricular remodeling: Mechanisms and prevention

Cardiology Clinics

Volumn 16, Issue 4, 1998, Pages 623-632

  Goldstein, S ^a   Ali, A S ^a   Sabbah, H ^a  

^a HENRY FORD HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; GLYCERYL TRINITRATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; DISEASE COURSE; DRUG MECHANISM; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VENTRICLE REMODELING; HUMAN; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW;

EID: 0031768599     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70039-4     Document Type: Article

References (70)